IDXG
Interpace Biosciences, Inc. Common Stock
IDXG
IDXG
Delisted
IDXG was delisted on the 24th of February, 2021.
17 hedge funds and large institutions have $3.12M invested in Interpace Biosciences, Inc. Common Stock in 2018 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 4 increasing their positions, 2 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
Holders
17
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$200K | |
| 2 | +$100K | |
| 3 | +$44.8K | |
| 4 |
WP
WealthSource Partners
San Luis Obispo,
California
|
+$43K |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$23K |
Top Sellers
| 1 | -$32.4K | |
| 2 | -$9K | |
| 3 | -$8K | |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$2K |